Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-30

Clinical Trial Update: Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study reporting the distribution of PET tracers Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in normal volunteers, sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluorine-18 Fluorodeoxyglucose (fluorodeoxyglucose F-18)
  • Nitrogen-13 Ammonia (nitrogen-13 ammonia)
  • Rubidium-82 (rubidium-82)

Snippet

Sponsor: University of Michigan | Conditions: Heart Disease | Phase 1 | Status: COMPLETED